Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Cytomegalovirus Infection

  Free Subscription


Articles published in J Heart Lung Transplant

Retrieve available abstracts of 17 articles:
HTML format



Single Articles


    November 2020
  1. KANWAR MK, Khush KK, Pinney S, Sherman C, et al
    Impact of cytomegalovirus infection on gene expression profile in heart transplant recipients.
    J Heart Lung Transplant. 2020 Nov 22. pii: S1053-2498(20)31840.
    PubMed     Abstract available


    August 2020
  2. STANKOVIC S, Davey MS, Shaw EM, von Borstel A, et al
    Cytomegalovirus replication is associated with enrichment of distinct gammadelta T cell subsets following lung transplantation: A novel therapeutic approach?
    J Heart Lung Transplant. 2020 Aug 26. pii: S1053-2498(20)31703.
    PubMed     Abstract available


    April 2020
  3. VP RIBEIRO R, Ku T, Ferreira VH, Galasso M, et al
    Targeting Latent Human Cytomegalovirus (CMV) with a Novel Fusion Toxin Protein during Ex Vivo Lung Perfusion.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  4. KANWAR M, Pinney S, Shah P, Kobashigawa J, et al
    Correlation of Longitudinal Gene-Expression Profiling (GEP) Score to Cytomegalovirus (CMV) Infection: Results from the Outcomes Allomap(R) Registry.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  5. STANKOVIC S, Davey MS, Shaw EM, Cristiano Y, et al
    A Potential Role for NKG2C+ gammadelta T Cells as a Cellular Therapy in Combating Post-Lung Transplant Cytomegalovirus Infection.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  6. PIERCE BJ, Pham C, Balk SV, Huang H, et al
    Cytomegalovirus Immune Globulin (CMV-Ig): An Old Drug with Fewer Tricks - Removal of Prophylactic CMV-Ig Administration in CMV Mismatched Lung Transplant Recipients.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  7. GIFT T, Palafox J, Jones K, Imburgia T, et al
    CMV Viremia after Discontinuation of Valganciclovir Prophylaxis in Lung Transplant Recipients.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  8. MOSS I, Brueckner A, Rumore A
    Comparison of Outcomes in Heart Transplant Recipients Receiving CMV Prophylaxis with CMV IVIG with Valganciclovir versus Valganciclovir Alone.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  9. COUTANCE G, Boutolleau D, Rouvier P, Leprince P, et al
    Cytomegalovirus Infections are Frequent after Heart Transplantation but Do Not Increase the Risk of Biopsy-Proven Allograft Rejection in the Modern Era.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  10. PUING A, Couture-Cosette A, Quintero O, Multani A, et al
    6-month vs 12-month CMV Prophylaxis for CMV-Mismatched Heart Transplant Recipients.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  11. CALLAN PD, Yonan N, Santhanakrishnan K, Shaw SM, et al
    Does CMV Status Impact on Morbidity and Survival Following Heart Transplantation? A Large Multi-Centre Retrospective UK Study.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


    January 2020
  12. POGLAJEN G, Zemljic G, Frljak S, Cerar A, et al
    QuantiFERON-CMV guided virostatic prophylaxis after heart transplantation.
    J Heart Lung Transplant. 2020 Jan 21. pii: S1053-2498(20)30010.
    PubMed    


    September 2019
  13. HELIOVAARA E, Husain S, Martinu T, Singer LG, et al
    Drug-resistant cytomegalovirus infection after lung transplantation: Incidence, characteristics, and clinical outcomes.
    J Heart Lung Transplant. 2019 Sep 10. pii: S1053-2498(19)31672.
    PubMed     Abstract available


    January 2019
  14. MOAYEDI Y, Gomez CA, Fan CPS, Miller RJH, et al
    Infectious complications after heart transplantation in patients screened with gene expression profiling.
    J Heart Lung Transplant. 2019 Jan 7. pii: S1053-2498(19)30006.
    PubMed     Abstract available


    July 2017
  15. VIETZEN H, Gorzer I, Honsig C, Jaksch P, et al
    Association between antibody functions and human cytomegalovirus (HCMV) replication after lung transplantation in HCMV-seropositive patients.
    J Heart Lung Transplant. 2017 Jul 18. pii: S1053-2498(17)31901.
    PubMed    


    May 2017
  16. SARMIENTO E, Jaramillo M, Calahorra L, Fernandez-Yanez J, et al
    Evaluation of humoral immunity profiles to identify heart recipients at risk for development of severe infections: A multicenter prospective study.
    J Heart Lung Transplant. 2017;36:529-539.
    PubMed     Abstract available


    August 2016
  17. FORCONI C, Gatault P, Miquelestorena-Standley E, Noble J, et al
    Polymorphism in programmed cell death 1 gene is strongly associated with lung and kidney allograft survival in recipients from CMV-positive donors.
    J Heart Lung Transplant. 2016 Aug 26. pii: S1053-2498(16)30295.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Cytomegalovirus Infection is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: